Globe Life (GL) to Release Quarterly Earnings on Monday

Globe Life (NYSE:GLGet Free Report) is scheduled to be announcing its earnings results after the market closes on Monday, April 22nd. Analysts expect the company to announce earnings of $2.80 per share for the quarter. Globe Life has set its FY24 guidance at $11.30-$11.80 EPS and its FY 2024 guidance at 11.300-11.800 EPS.Investors that are interested in participating in the company’s conference call can do so using this link.

Globe Life (NYSE:GLGet Free Report) last released its quarterly earnings results on Wednesday, February 7th. The company reported $2.88 EPS for the quarter, beating the consensus estimate of $2.73 by $0.15. Globe Life had a net margin of 17.82% and a return on equity of 24.25%. The firm had revenue of $1.42 billion during the quarter, compared to analyst estimates of $1.40 billion. During the same quarter in the prior year, the firm earned $2.24 EPS. The business’s revenue for the quarter was up 6.0% compared to the same quarter last year. On average, analysts expect Globe Life to post $12 EPS for the current fiscal year and $13 EPS for the next fiscal year.

Globe Life Price Performance

NYSE GL opened at $66.74 on Friday. Globe Life has a 52 week low of $38.95 and a 52 week high of $132.00. The firm has a market capitalization of $6.28 billion, a P/E ratio of 6.62 and a beta of 0.69. The company has a quick ratio of 0.05, a current ratio of 0.05 and a debt-to-equity ratio of 0.36. The company has a 50-day moving average price of $111.78 and a 200-day moving average price of $116.54.

Globe Life Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, May 1st. Stockholders of record on Friday, April 5th will be given a dividend of $0.24 per share. The ex-dividend date is Thursday, April 4th. This represents a $0.96 annualized dividend and a dividend yield of 1.44%. This is a positive change from Globe Life’s previous quarterly dividend of $0.23. Globe Life’s dividend payout ratio is presently 9.52%.

Institutional Trading of Globe Life

Several hedge funds have recently modified their holdings of GL. JPMorgan Chase & Co. raised its holdings in Globe Life by 7.2% during the 1st quarter. JPMorgan Chase & Co. now owns 93,908 shares of the company’s stock valued at $9,448,000 after buying an additional 6,299 shares during the period. Raymond James Financial Services Advisors Inc. boosted its stake in shares of Globe Life by 3.8% during the 1st quarter. Raymond James Financial Services Advisors Inc. now owns 14,549 shares of the company’s stock worth $1,464,000 after purchasing an additional 538 shares during the period. American Century Companies Inc. boosted its stake in shares of Globe Life by 26.8% during the 1st quarter. American Century Companies Inc. now owns 13,456 shares of the company’s stock worth $1,354,000 after purchasing an additional 2,848 shares during the period. Cetera Advisor Networks LLC boosted its stake in shares of Globe Life by 3.0% during the 1st quarter. Cetera Advisor Networks LLC now owns 4,740 shares of the company’s stock worth $477,000 after purchasing an additional 137 shares during the period. Finally, MetLife Investment Management LLC boosted its stake in shares of Globe Life by 23.9% during the 1st quarter. MetLife Investment Management LLC now owns 25,421 shares of the company’s stock worth $2,557,000 after purchasing an additional 4,897 shares during the period. 81.61% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several equities research analysts have recently commented on GL shares. Keefe, Bruyette & Woods reduced their price target on shares of Globe Life from $135.00 to $130.00 and set a “market perform” rating for the company in a research report on Wednesday, April 10th. Wells Fargo & Company cut their price objective on Globe Life from $146.00 to $132.00 and set an “overweight” rating for the company in a research note on Thursday, April 11th. StockNews.com upgraded Globe Life from a “hold” rating to a “buy” rating in a research note on Friday, April 12th. Evercore ISI cut their price objective on Globe Life from $125.00 to $75.00 and set an “in-line” rating for the company in a research note on Friday, April 12th. Finally, Truist Financial reiterated a “hold” rating and set a $125.00 price objective on shares of Globe Life in a research note on Friday, April 12th. Five research analysts have rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, Globe Life presently has an average rating of “Moderate Buy” and a consensus price target of $126.44.

Read Our Latest Stock Analysis on GL

About Globe Life

(Get Free Report)

Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.

Featured Articles

Earnings History for Globe Life (NYSE:GL)

Receive News & Ratings for Globe Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Globe Life and related companies with MarketBeat.com's FREE daily email newsletter.